<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01410591</url>
  </required_header>
  <id_info>
    <org_study_id>T8/10CSVB</org_study_id>
    <secondary_id>FMMU-XHDD 003</secondary_id>
    <nct_id>NCT01410591</nct_id>
  </id_info>
  <brief_title>TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding</brief_title>
  <acronym>T8/10SVB</acronym>
  <official_title>The Effect of TIPS With 8- or 10-mm Covered Stent for Preventing Variceal Rebleeding in Cirrhotic Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fourth Military Medical University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether transjugular intrahepatic portosystemic
      shunt (TIPS) with 10-mm covered stent is associated with lower shunt dysfunction in comparing
      TIPS with 8-mm covered stent in cirrhotic patients with at least one episode of variceal
      bleeding.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of shunt dysfunction.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of variceal rebleeding</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hepatic encephalopathy</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hepatic myelopathy</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">127</enrollment>
  <condition>Decompensated Cirrhosis</condition>
  <condition>Portal Hypertension</condition>
  <condition>Bleeding Varices</condition>
  <arm_group>
    <arm_group_label>10-mm covered stent group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with 10-mm covered stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8-mm covered stent group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with 8-mm covered stent.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>8-mm covered stent group</intervention_name>
    <description>Creating a shunt between hepatic vein and portal vein with a 8-mm covered stent by TIPS procedure.</description>
    <arm_group_label>8-mm covered stent group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>10-mm covered stent group</intervention_name>
    <description>Creating a shunt between hepatic vein and portal vein with a 10-mm covered stent by TIPS procedure.</description>
    <arm_group_label>10-mm covered stent group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cirrhotic patients with at least one episode of variceal bleeding

          -  No active bleeding within 5 days before TIPS

          -  Child-Pugh score â‰¤13

          -  Signed written informed consent

        Exclusion Criteria:

          -  An age &lt;18 years or &gt;75 years

          -  With TIPS contraindications

          -  Past or present history of hepatic encephalopathy

          -  Pregnancy or breast-feeding

          -  Hepatic carcinoma and/or other malignancy diseases

          -  Sepsis

          -  Spontaneous bacterial peritonitis

          -  Uncontrollable hypertension

          -  Serious cardiac or pulmonary dysfunction

          -  Renal failure

          -  Portal vein thrombosis

          -  History of organ transplantation

          -  History of HIV (human immunodeficiency viruses) infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guohong Han, PhD &amp; MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing Hospital of Digestive Diseases, Fourth Military Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xijing Hospital of Digestive Diseases, Fourth Military Medical University</name>
      <address>
        <city>Xi`an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, Fanelli F, Merli M, Salvatori FM. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol. 2010 Aug;53(2):267-72. doi: 10.1016/j.jhep.2010.02.033. Epub 2010 Apr 27.</citation>
    <PMID>20537753</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2011</study_first_submitted>
  <study_first_submitted_qc>August 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2011</study_first_posted>
  <last_update_submitted>January 23, 2016</last_update_submitted>
  <last_update_submitted_qc>January 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fourth Military Medical University</investigator_affiliation>
    <investigator_full_name>Guohong Han</investigator_full_name>
    <investigator_title>Head of Department of Digestive Interventional Radiology</investigator_title>
  </responsible_party>
  <keyword>transjugular intrahepatic portosystemic shunt</keyword>
  <keyword>TIPS</keyword>
  <keyword>liver cirrhosis</keyword>
  <keyword>variceal bleeding</keyword>
  <keyword>8- or 10-mm covered stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

